News
The Ebola drug was flown to Spain to give to a priest named Miguel Pajares, who had contracted the virus in Liberia. Pajares died on August 12. It’s unclear if he was given the drug before he died.
Ebola Declared an International Health Emergency. Ebola Outbreak: CDC is on Highest Alert. Two American health workers survived Ebola after receiving the drug, but it's unclear if the medication ...
NEW: Ebola drug ZMapp can be produced using tobacco plant proteins. Ebola drug given to Americans developed by a company based in San Diego. It's unclear whether the drug will be administered to ...
After killing at least 9,936 people and infecting more than 24,202, the Ebola epidemic appears to be running out of steam. New Ebola cases are declining: Why that's bad news for a cure - Los ...
A: Canada's Tekmira Pharmaceuticals Corp. is developing a drug that targets Ebola's genetic material. The FDA had halted a small safety study with questions about a reaction in healthy volunteers ...
The Ebola outbreak in North Kivu seems to have come to an end just as the coronavirus panic struck Europe and the U.S.—the WHO says there has not been a new case of Ebola since Feb. 17 this year.
Why Ebola drug seems so elusive: Column. Scott Gottlieb. The emergence of a third case of Ebola in Dallas shows us that the deadly infection, while less transmissible than viruses such as the flu, ...
In the midst of the 2014 Ebola outbreak, a drug called ZMapp was one of the most promising treatments for the disease. But now researchers have published a study of the medication in people, and ...
The Ebola Drug Pipeline. The World Health Organization has said that it is ethical to use unproven drugs in the current epidemic. In the United States, the Food and Drug Administration has granted ...
Today, drug research for Ebola continues in West Africa. This summer, a vaccine candidate, VSV-EBOV, manufactured by the pharmaceutical companies NewLink Genetics and Merck, made headlines.
Assuming the drug seems safe, it would be ready for testing in a future outbreak of Ebola. Of course, most potential drugs don't live up to their early promise, and there's no assurance this one ...
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results